The AHSN National Polypharmacy Programme was launched in April 2022. The core principle of the programme is to support local systems to address problematic polypharmacy by using data to identify patients at potential risk of harm and support better conversations about medicines.

The programme is based on three core principles supported by a local community of practice to drive changes in practice:

  1. Population health management
    Using data (NHSBSA polypharmacy prescribing comparators) to understand population health risks and support prioritisation of patients for a structured medication review.
  2. Education and training
    Running local Polypharmacy Action Learning Sets (ALSs) to upskill the primary care workforce to be more confident about stopping unnecessary medicines.
  3. Public behaviour change
    The testing and evaluation of public-facing interventions to challenge and change public perceptions of prescribing and encourage patients to talk about medicines.

WE NEED YOU!

  • Prescribers (medical and non-medical) working in primary care with 12+ months experience to become accredited National AHSN Polypharmacy Action Learning Set Trainer.
  • Passionate geriatricians to share their experience as clinical champions.
  • To join our Polypharmacy – learning collaborative (community of practice): an open forum to share successes and challenges across the region and an opportunity to network with colleagues from all sectors.

To read more about this programme, visit the: AHSN’s polypharmacy webpage

To join your local community of practice, or find out how to get involved in the programme, please email: Jordan.Leith@wmahsn.org.

Latest Opportunities

Single manufacturer & supplier required for human skin patch: Formulation, manufacture, and packing

Opportunity Company:  Nottingham-based MedTech company Requires: Seeking a single manufacturer and supplier for the formulation,…

Medilink Midlands Job Vacancy - Innovation Adviser

About the job Innovation Adviser – Midlands region – Full time salary £40-45K – Home…

Global Business Innovation Programme: Health & Medical Technologies - Singapore

Innovate UK is inviting ambitious innovative companies to participate in its Global Business Innovation Programme…

Latest News

Cambridge Sleep Sciences Unveils World-First Performance Pillow That Adapts to Users’ Sleep

Cambridge Sleep Sciences Unveils World-First Performance Pillow That Adapts to Users’ Sleep – Helping Gamers…

Kindeva Opens New UK HQ and Manufacturing Site for the Development of Next-Generation Propellants

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters…

EU MDR/IVDR Revision: A Gateway for Chinese Innovators Entering UK and EU Markets via EFEC

In a significant move for the global medtech landscape, the European Commission has initiated a…